Transcatheter renal sympathetic ablation for resistant hypertension: In vivo insights in humans from optical coherence tomography

International Journal of Cardiology

Volumn 165, Issue 2, 2013, Pages

  Ierna, Salvatore ^a   Biondi Zoccai, Giuseppe ^b,c   Bachis, Claudia ^a   Occhipinti, Michele ^c   Di Vito, Luca ^e   Ricciardi, Andrea ^c   Pappone, Carlo ^d   Prati, Francesco ^c,e  

^a Sirai Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Centro per la Lotta contro l'Infarto (CLI) Foundation   (Italy)

^d Research Ettore Sansavini Health Science Foundation   (Italy)

^e SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

Optical coherence tomography; Renal denervation; Resistant hypertension

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ARTERIAL STENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CASE REPORT; CATHETER ABLATION; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; HYPERTENSION; IN VIVO STUDY; KIDNEY DENERVATION; LETTER; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PRIORITY JOURNAL; RENAL ARTERY; RENAL ARTERY THROMBOSIS; RENOVASCULAR HYPERTENSION; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ARTERIAL WALL THICKNESS; KIDNEY DENERVATION SYSTEM; MIDDLE AGED; RENAL ARTERY STENTING; THROMBOSIS; UROLOGICAL PROCEDURE;

EID: 84876694121     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.056     Document Type: Article

References (9)

1. V. Papademetriou, M. Doumas, and K. Tsioufis Renal sympathetic denervation for the treatment of difficult-to-control or resistant hypertension Int J Hypertens 2011 2011 196518
2. M.K. Rippy, D. Zarins, N.C. Barman, A. Wu, K.L. Duncan, and C.K. Zarins Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety Clin Res Cardiol 100 2011 1095 1101
3. H. Krum, M. Schlaich, and R. Whitbourn Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
4. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 36 2009 932 934
5. M.P. Schlaich, P.A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M.D. Esler Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept Hypertension 54 2009 1195 1201
6. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Böhm Symplicity HTN-2 investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
7. F. Imola, M.T. Mallus, and V. Ramazzotti Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention EuroIntervention 6 2010 575 581
8. F. Prati, M. Cera, and V. Ramazzotti From bench to bedside: a novel technique of acquiring OCT images Circ J 72 2008 839 843
9. F. Prati, E. Regar, and G.S. Mintz Expert's OCT review document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis Eur Heart J 31 2010 401 415